SIGMA M1633-250MG 4-甲基伞形酮 β-D-吡喃半乳糖苷 6160-78-7
文献支持

SIGMA M1633-250MG 4-甲基伞形酮 β-D-

吡喃半乳糖苷 6160-78-7
收藏
  • ¥571
  • Sigma-Aldrich
  • 进口
  • M1633-250MG
  • 2025年07月16日
    avatar
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 文献和实验
    • 技术资料
    • 保存条件

      −20°C

    • 保质期

      根据瓶身LOT号查询

    • 英文名

      4-Methylumbelliferyl β-D-galactopyranoside

    • 库存

      有现货

    • 供应商

      浙江羽翔生物科技有限公司

    • CAS号

      6160-78-7

    • 规格

      250MG

    属性

    产品名称

    4-甲基伞形酮 β-D-吡喃半乳糖苷, ≥99% (TLC)

    方案

    ≥99% (TLC)

    表单

    powder

    溶解性

    pyridine: 10 mg/mL, clear, colorless to faintly yellow

    储存温度

    −20°C

    SMILES字符串

    CC1=CC(=O)Oc2cc(O[C@@H]3O[C@H](CO)[C@H](O)[C@H](O)[C@H]3O)ccc12

    InChI

    1S/C16H18O8/c1-7-4-12(18)23-10-5-8(2-3-9(7)10)22-16-15(21)14(20)13(19)11(6-17)24-16/h2-5,11,13-17,19-21H,6H2,1H3/t11-,13+,14+,15-,16-/m1/s1

    InChI key

    YUDPTGPSBJVHCN-DZQJYWQESA-N

    一般描述

    4-甲基伞形酮β-D-吡喃半乳糖苷(MUG)是一种紫外线吸收染料,在平面酵母雌激素筛(pYES)中用作β-半乳糖苷酶的荧光底物,检测雌激素活性化合物。

    应用

    4-甲基伞形酮β-D-吡喃半乳糖苷已用作β-半乳糖苷酶活性测定底物。

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    该产品被引用文献

    Differences in gene expression patterns, revealed by RNA-seq analysis, between various Sanfilippo and Morquio disease subtypes.

    Gene (2021-12-14)
    Karolina Wiśniewska, Lidia Gaffke, Karolina Krzelowska, Grzegorz Węgrzyn, Karolina Pierzynowska
    PMID34896230
    摘要

    Mucopolysaccharidoses (MPS) are genetic disorders that affect up to 1 in 25,000 births. They are caused by dysfunctions of lysosomal hydrolases that degrade glycosaminoglycans (GAGs) which accumulate in cells, damaging their proper functioning. There are 7 types of MPS, distinguished by the kind of accumulated GAG and the defective enzyme, which differ significantly in the course of the disease. Despite the storage of the same GAGs, two of them (MPS III and IV) are divided into subtypes. While the course of MPS IV A and B is similar, the variability between MPS III A, B, C and D is high. This suggests that there are additional aspects that could influence the course of the disease. Therefore, the aim of this study was to determine differences of patterns of gene expression between all MPS III and IV subtypes. Transcriptomic studies, carried out with dermal fibroblasts from patients with all MPS III and IV subtypes, showed a significant variation in the gene expression pattern between individual MPS III subtypes, in contrast to MPS IV. Detailed analysis of transcripts with altered expression levels between MPS III subtypes indicated that these transcripts are mainly involved in maintaining the proper structure of connective tissue (COL4A1, COL4A2, COMP) and the structure of ribosomes (RPL10, RPL23, RPLP2). The results presented in this study indicate a significant role of genetic factors in the diversified course of MPS III subtypes.

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥691
    嘉兴亦高医疗器械有限公司
    2025年10月18日询价
    ¥225
    上海梵态生物科技有限公司
    2025年07月16日询价
    ¥360
    上海源叶生物科技有限公司
    2025年10月29日询价
    询价
    上海齐源生物科技有限公司
    2023年10月18日询价
    询价
    上海邦景实业有限公司
    2025年07月14日询价
    文献支持
    SIGMA M1633-250MG 4-甲基伞形酮 β-D-吡喃半乳糖苷 6160-78-7
    ¥571